Valproate in Adjuvant Glioblastoma Treatment.
University of Newcastle; Genesis Cancer Care; Calvary Mater Hospital; Newcastle, New South Wales; University of Queensland, Brisbane, Queensland, Australia mike.fay@cancer.com.au.
Michael F
MF
Fay
University of South Australia, Adelaide, South Australia, Australia.
Richard
R
Head
VU University, Amsterdam, the Netherlands.
Peter
P
Sminia
CSIRO, Brisbane, Queensland, Australia.
Nicholas
N
Dowson
CSIRO, Adelaide, South Australia, Australia.
Leah
L
Cosgrove
CSIRO; University of Queensland, Brisbane, Queensland, Australia.
Stephen E
SE
Rose
University of Newcastle; Calvary Mater Hospital, Newcastle, New South Wales; University of Queensland, Brisbane, Queensland, Australia.
Jenny H
JH
Martin
D018906:Antineoplastic Agents, Alkylating; D001932:Brain Neoplasms; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003606:Dacarbazine; D005909:Glioblastoma; D006801:Humans; D016896:Treatment Outcome; D014635:Valproic Acid
D018906:Antineoplastic Agents, Alkylating; D014635:Valproic Acid; D003606:Dacarbazine